Monopar Therapeutics Inc. (MNPR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$53.94
Day's range
$58.4

Monopar Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JUPITER TOPCO LLC 08/14/2026 1.31 M $121.70 M   100.00% 15.36%
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 667.21 K $61.78 M   0.00% 7.81%
BLACKROCK, INC. 08/07/2026 348.82 K $32.30 M   10.19% 4.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 323.75 K $29.98 M   0.00% 3.79%
SATURN V CAPITAL MANAGEMENT LLC 08/14/2026 311.98 K $28.89 M   -9.74% 3.65%
SIREN, L.L.C. 08/13/2026 270.12 K $25.01 M   0.00% 3.16%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 217.60 K $20.15 M   -17.66% 2.55%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 214.47 K $19.86 M   -5.32% 2.51%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 209.71 K $19.42 M   -4.01% 2.45%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 209.20 K $19.37 M   -32.34% 2.45%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 203.33 K $18.83 M   53.92% 2.38%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 158.44 K $14.67 M   -9.12% 1.85%
ORBIMED ADVISORS LLC 08/14/2026 157.42 K $14.58 M   100.00% 1.84%
CANDRIAM S.C.A. 08/13/2026 143.34 K $13.26 M   100.00% 1.68%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 134.54 K $12.46 M   -1.39% 1.58%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 112.58 K $10.43 M   12.67% 1.32%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 100.00 K $9.26 M   0.00% 1.17%
STATE STREET CORP 08/07/2026 92.55 K $8.57 M   4.75% 1.08%
VIVO CAPITAL, LLC 08/14/2026 90.50 K $8.38 M   0.00% 1.06%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 84.04 K $7.78 M   153.47% 0.98%
BANK OF NEW YORK MELLON CORP 08/06/2026 76.94 K $7.12 M   -2.13% 0.90%
VESTAL POINT CAPITAL, LP 08/14/2026 75.73 K $7.01 M   15.76% 0.89%
LONGAEVA PARTNERS L.P. 08/14/2026 55.83 K $5.17 M   100.00% 0.65%
NEUBERGER BERMAN GROUP LLC 08/13/2026 55.19 K $5.11 M   30.07% 0.65%
MILLENNIUM MANAGEMENT LLC 08/14/2026 50.31 K $4.66 M   -4.99% 0.59%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 48.82 K $4.52 M   6.15% 0.57%
IKARIAN CAPITAL, LLC 08/14/2026 47.86 K $4.43 M   100.00% 0.56%
CITADEL ADVISORS LLC 09/02/2026 37.00 K $3.43 M   -36.68% 0.43%
NORTHERN TRUST CORP 08/13/2026 34.64 K $3.21 M   8.72% 0.41%
DEUTSCHE BANK AG\ 08/07/2026 31.01 K $2.87 M   7.58% 0.36%
STEMPOINT CAPITAL LP 08/14/2026 30.13 K $2.79 M   100.00% 0.35%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 28.28 K $2.62 M   -0.59% 0.33%
UBS GROUP AG 08/13/2026 27.26 K $2.52 M   -30.88% 0.32%
MORGAN STANLEY 08/13/2026 17.92 K $1.66 M   -19.69% 0.21%
AMERIPRISE FINANCIAL INC 08/14/2026 17.80 K $1.65 M   161.04% 0.21%
GOLDMAN SACHS GROUP INC 08/14/2026 16.16 K $1.50 M   -53.44% 0.19%
RUSSELL INVESTMENTS GROUP, LTD. 08/06/2026 14.85 K $1.37 M   4.22% 0.17%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 14.69 K $1.36 M   100.00% 0.17%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 13.95 K $1.29 M   11.11% 0.16%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 13.95 K $1.29 M   100.00% 0.16%
ISHARA INVESTMENTS LP 08/14/2026 12.30 K $1.14 M   100.00% 0.14%
TWO SIGMA INVESTMENTS, LP 08/14/2026 12.25 K $1.13 M   25.47% 0.14%
TREXQUANT INVESTMENT LP 08/14/2026 12.00 K $1.11 M   100.00% 0.14%
CREATIVE PLANNING 08/13/2026 7.77 K $719.24 K   29.75% 0.09%
GSA CAPITAL PARTNERS LLP 08/06/2026 7.53 K $697.00 K   100.00% 0.09%
XTX TOPCO LTD 08/14/2026 6.54 K $605.17 K   100.00% 0.08%
NUVEEN, LLC 08/11/2026 5.98 K $553.69 K   7.73% 0.07%
BARCLAYS PLC 08/14/2026 5.83 K $540.08 K   -76.61% 0.07%
RHUMBLINE ADVISERS 08/12/2026 5.63 K $521.27 K   13.83% 0.07%
GERBER, LLC 07/29/2026 5.60 K $518.60 K   0.00% 0.07%

Monopar Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 118 institutional investors and hedge funds held shares of Monopar Therapeutics Inc. The most heavily invested institutionals were:

Jupiter Topco LLC: 1.31 M

RA CAPITAL MANAGEMENT, L.P.: 667,207

BlackRock, Inc.: 348,819

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 323,745

Saturn V Capital Management LLC: 311,976

Siren, L.L.C.: 270,118

73.00% of Monopar Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 7.85 M shares in the last 24 months. This purchase volume represents approximately $455.82 M in transactions.